The Immuno-Oncology Summit will return to Boston again this August 28-September 1 with the goal of supporting researchers in developing the next generation of immunotherapies. Immuno-oncology researchers are changing the way we treat cancer by unleashing the immune system and achieving functional cures in some cancers. This year's IO Summit has been designed to give attendees a complete picture of the field and its advances with 12 conference tracks, 1 in-depth training seminar, and 3 instructional short courses. Topics include immunotherapy discovery, development, biomarkers, and translational oncology as well as emerging topic areas such as cancer vaccines, oncolytic viruses, and advances in synthetic biology techniques. Overall, this event provides a focused look at how researchers are applying new science and technology in the development of effective and safe immunotherapies.

RECORD ATTENDANCE!
JOIN OVER 500 INTERNATIONAL IMMUNO-ONCOLOGY THOUGHT LEADERS!

View current list of pre-registered delegates!

Plenary Keynotes

Graeme E. Price, Ph.D.

Research Microbiologist,

Gene Transfer & Immunogenicity, FDA CBER


Gergana ZlatevaGergana Zlateva, Ph.D.,

Vice President

Payer Insights and Access, Oncology, Pfizer


Learn more

Sponsorship and Exhibit


Short Courses


Hotel Travel


 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag

Register Today
Celebrating 25 Years

Premier Sponsor

Natera




2017 Download Brochure


IPR_IMX_Banner